主管高峰会议 : Implementing a Biomarker Strategy for Better Decision Making
教学课程 : BioMmarker Assay Development and Validation
研讨会 : Cancer Biomarkers
The Biomarker World Congress 2008是Cambridge Healthtech Institute主办的生物标记系列中最受瞩目的活动。内容涵盖从创药开始到诊断流程之各生物标记相关研究领域。本会议将吸引大规模、中规模之制药企业、生技企业、诊断检验企业、主要大学、临床机关、政府国家研究机关、 CRO、新兴企业、器具制造企业等特定之参加者齐聚。与会者可以互相分享宝贵经验、强化商业及学术合作交流、评估革新技术等。此外，本会议均衡提供各种内容，包含最新研究相关技术之主题、战略之发表、专为决策者设计的集体研讨等活动。
会议主题
转译医学之生物标记
药物基因体学
生物标记检验的开发和检证
分子诊断用生物标记
生物标记的临床试验
安全性评价及临床药理学之生物标记
病患选择及治疗即时观察用之生物标记
生物标记特定战略
遗传学、蛋白质体学、代谢体学用生物标记
特定疾病用生物标记: 癌、CNS、发炎性病患
决定go/no-go之生物标记
规制问题
会前研讨会教学课程(本课程必须另行申请。)
以目的作分类之生物标记检验的开发和检证
讲师
John L. Allinson, FIBMS, Director, Veeda Clinical Research Ltd.; and Viswanath Devanarayan, Ph.D., Director, Statistics, Biomarker Research, Abbott Laboratories
本会议中预定发表之一部分
Biomarkers for Pharmacodynamics and Patient Stratification Scott Patterson, Ph.D., Executive Director, Medical Sciences, Amgen Inc.
Alzheimer's Disease Biomarker Discovery: From Focused Analytes to Open Discovery Adam J. Simon, Ph.D., Senior Research Fellow, Biomarkers, Integrative Systems Neuroscience, Merck Research Laboratories
Genomic Signature Biomarkers for Bile Duct Hyperplasia Jeffrey F. Waring, Ph.D., Associate Research Fellow, Group Leader, Abbott Laboratories
Efficacy and Mechanism of Action-based Biomarkers: from Assay Development to Clinical Data Raffaella Castoldi, M.S., Head of Analytical Biology, DMPK, Accelera/Nerviano Medical Sciences
Novel Biomarker Assays: from Preclinical Development to Clinical Proof of Concept Miro Venturi, Ph.D., Novartis Biologics
Biomarkers for Clinical Development in Alzheimer Disease and Multiple Sclerosis Christine Bétard, Ph.D, Senior Director, Global Strategic Drug Development Unit, Quintiles Benefit France SNC
Classification Biomarkers in Psychiatry by "Omic" Approaches Enrico Domenici, Ph.D., Director, Molecular Psychiatry, GSK Medicines Research Centre
Identification of Bcl-2 Family Members as Biomarkers of Response to ABT-263 Treatment Stephen Tahir, Ph.D., Research Investigator, Cancer, Abbott Laboratories
Strategies to Tackle Matrix Effects in Biomarker Assays Ole Lagatie, Ph.D., Scientific Advisor, Bioanalysis, Eurofins Medinet
Imaging MALDI vs. Histologic Imaging of Cancer of the Colon- A new Diagnostic Paradigm Paul H. Pevsner, M.D., Research Associate Professor of Pharmacology, New York University School of Medicine
Comparison of Different Biomarker Endpoints for Carcinogenesis of Aristolochic Acid in Rats Tao Chen, Ph.D., Research Toxicologist, Division of Genetic and Reproductive Toxicology, FDA/NCTR
Organ and Species Comparisons of Metabolic Disease Biomarkers in Mice and Humans Andreas Freidig, Ph.D., Dr., BU Biosciences, TNO, Quality of Life
